"Cytochrome P-450 CYP2C19" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A cytochrome P-450 enzyme subtype that oxidizes several important groups of drugs including many PROTON PUMP INHIBITORS and ANTICONVULSANTS.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D065731
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D08.244.453.491.500.700 D08.811.682.690.708.170.450.500.700 D12.776.422.220.453.491.500.700 
						 | 
					
					
						| Concept/Terms | 
						
							Cytochrome P-450 CYP2C19- Cytochrome P-450 CYP2C19
 - CYP2C19, Cytochrome P-450
 - Cytochrome P 450 CYP2C19
 - P-450 CYP2C19, Cytochrome
 - CYPIIC19
 - S-Mephenytoin 4'-Hydroxylase
 - 4'-Hydroxylase, S-Mephenytoin
 - S Mephenytoin 4' Hydroxylase
 - CYP2C19
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP2C19".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP2C19".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Cytochrome P-450 CYP2C19" by people in this website by year, and whether "Cytochrome P-450 CYP2C19" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2013 | 0 | 1 | 1 | 
| 2016 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Cytochrome P-450 CYP2C19" by people in Profiles.
						
					
								- 
								
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity. Clin Pharmacol Ther. 2016 09; 100(3):287-94.
															
								 
							
								- 
								
An allele-specific PCR system for rapid detection and discrimination of the CYP2C19*4A, *4B, and *17 alleles: implications for clopidogrel response testing. J Mol Diagn. 2013 Nov; 15(6):783-9.